Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003217622 | SCV003907664 | uncertain significance | Inborn genetic diseases | 2023-03-10 | criteria provided, single submitter | clinical testing | The c.4276A>C (p.K1426Q) alteration is located in exon 31 (coding exon 31) of the DST gene. This alteration results from a A to C substitution at nucleotide position 4276, causing the lysine (K) at amino acid position 1426 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003481471 | SCV004227279 | uncertain significance | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | BP4, PM2 |